lobbying_activities: 2060126
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2060126 | 1fbce463-11a4-4a27-90e9-c942aa0c4fdb | Q4 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2017 | fourth_quarter | MMM | AACC met with legislators and congressional staff, sent letters, initiated several grassroots campaigns, and joined with other healthcare groups in urging that the Centers for Medicare and Medicaid Services revise its new proposed clinical laboratory fee schedule to include more payment data from a greater cross-section of the laboratory community. CMS was required to revise the CLFS to reflect private sector payment rates under Section 216 of the Protecting Access to Medicare Act. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2018-01-11T11:23:07.593000-05:00 |